Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer

Bayne, Lauren J., Beatty, Gregory L., Jhala, Nirag, Clark, Carolyn E., Rhim, Andrew D., Stanger, Ben Z., Vonderheide, Robert H.·2012·Cancer Cell

Cited by (952)

Items 501–600 of 952

  1. Tumor Microenvironment in Pancreatic Intraepithelial Neoplasia
    Friederike V. Opitz, Lena Häberle, Alexandra Daum, Iréne Esposito · 2021 · Cancers
  2. B Cell Receptor Signaling and Protein Kinase D2 Support Regulatory B Cell Function in Pancreatic Cancer
    Daniel E. Michaud, Bhalchandra Mirlekar, Colleen R. Steward, Gail Abendroth Bishop, Yuliya Pylayeva‐Gupta · 2022 · Frontiers in Immunology
  3. βig-h3-structured collagen alters macrophage phenotype and function in pancreatic cancer
    Sophie Bachy, Zhichong Wu, Pia Gamradt, Kevin Thierry, Pascale Milani, Julien Chlasta, Anà Hennino · 2022 · iScience
  4. Update on oncolytic viral therapy – targeting angiogenesis
    James Russell Tysome, Nicholas Robert Lemoine, Yaohe Wang · 2013 · OncoTargets and Therapy
  5. GM-CSF Promotes Antitumor Immunity by Inducing Th9 Cell Responses
    Il‐Kyu Kim, Choong‐Hyun Koh, Insu Jeon, Kwangsoo Shin, Tae-Seung Kang, Eun‐Ah Bae, Hyungseok Seo, Hyun‐Ja Ko, Byung‐Seok Kim, Yeonseok Chung et al. · 2019 · Cancer Immunology Research
  6. Emergency myelopoiesis in solid cancers
    Konstantinos Aliazis, Sasitorn Yenyuwadee, Ployploen Phikulsod, Vassiliki A. Boussiotis · 2024 · British Journal of Haematology
  7. Increased CD14+HLA-DR−/low Myeloid-Derived Suppressor Cells Correlate With Disease Severity in Systemic Lupus Erythematosus Patients in an iNOS-Dependent Manner
    Zhitao Wang, Fengfeng Zhu, Jiyu Wang, Qianshan Tao, Xuanxuan Xu, Huiping Wang, Shudao Xiong, Yiping Wang, Zhimin Zhai · 2019 · Frontiers in Immunology
  8. Inflammation and skeletal metastasis
    Hernan Roca, Laurie K. McCauley · 2015 · BoneKEy Reports
  9. PEDF inhibits pancreatic tumorigenesis by attenuating the fibro-inflammatory reaction
    Daniel R. Principe, Brian T. DeCant, Andrew M. Diaz, Riley J. Mangan, Rosa F. Hwang, Andrew M. Lowy, Brandon Shetuni, Bharath Krishnan Nair Sreekumar, Chuhan Chung, David J. Bentrem et al. · 2016 · Oncotarget
  10. Immune vulnerabilities of mutant KRAS in pancreatic cancer
    Noah C. Cheng, Robert H. Vonderheide · 2023 · Trends in cancer
  11. Tumor secretome shapes the immune landscape during cancer progression
    Jian-Qiang Yang, Sijia Tang, N. Saba, C. Shay, Yong Teng · 2025 · Journal of experimental & clinical cancer research : CR
  12. Molecular Mechanisms and Potential Therapeutic Reversal of Pancreatic Cancer-Induced Immune Evasion
    Li-Lian Gan, Ling‐Wei Hii, Shew Fung Wong, Chee‐Onn Leong, Chun‐Wai Mai · 2020 · Cancers
  13. Selective inhibition of mTORC1 in tumor vessels increases antitumor immunity
    Shan Wang, Ariel L. Raybuck, Eileen F. Shiuan, Sung Hoon Cho, Qingfei Wang, Dana M. Brantley‐Sieders, Deanna N. Edwards, Margaret M. Allaman, James A. Nathan, Keith T. Wilson et al. · 2020 · JCI Insight
  14. Embryonic Origin and Subclonal Evolution of Tumor-Associated Macrophages Imply Preventive Care for Cancer
    Xiaomei Zhang, De-Gao Chen, Shengwen Calvin Li, Bo Zhu, Zhongjun Li · 2021 · Cells
  15. The trilogy of P21 activated kinase, autophagy and immune evasion in pancreatic ductal adenocarcinoma
    Yi Ma, Mehrdad Nikfarjam, Hong Zhen He · 2022 · Cancer Letters
  16. Identification of a chemoresistance-related prognostic gene signature by comprehensive analysis and experimental validation in pancreatic cancer
    Junliang Chen, Zhihao Liu, Z. Wu, Wenjun Li, Xiaodong Tan · 2023 · Frontiers in Oncology
  17. Inflammation by Breast Implants and Adenocarcinoma: Not Always a Bad Company
    Monia Orciani, Giulia Sorgentoni, Fabiola Olivieri, Monica Mattioli‐Belmonte, Giovanni Di Benedetto, Roberto Di Primio · 2017 · Clinical Breast Cancer
  18. Microfluidic‐based, live‐cell analysis allows assessment of NK‐cell migration in response to crosstalk with dendritic cells
    Sajid Mahmood, Saravanan Nandagopal, Ibrahim Sow, Francis Lin, Sam K. P. Kung · 2014 · European Journal of Immunology
  19. A Novel Immunocompetent Mouse Model of Pancreatic Cancer with Robust Stroma: a Valuable Tool for Preclinical Evaluation of New Therapies
    Kaustav Majumder, Nivedita Arora, Shrey Modi, Rohit Chugh, Alice Nomura, Bhuwan Giri, Rajinder Kumar Dawra, Sundaram Ramakrishnan, Sulagna Banerjee, Ashok Kumar Saluja et al. · 2015 · Journal of Gastrointestinal Surgery
  20. Advances in Molecular Mechanisms and Immunotherapy Involving the Immune Cell-Promoted Epithelial-to-Mesenchymal Transition in Lung Cancer
    Serena De Matteis, Matteo Canale, Alberto Verlicchi, Giuseppe Bronte, Angelo Delmonte, Lucio Crinò, Giovanni Martinelli, Paola Ulivi · 2019 · Journal of Oncology
  21. Rab27a plays a dual role in metastatic propensity of pancreatic cancer
    Nancy Porterfield Kren, Daniel E. Michaud, Sukriti Bagchi, Kevin G. Greene, Yuliya Pylayeva‐Gupta · 2020 · Scientific Reports
  22. Characterization of the whole transcriptome of spleens from Chinese indigenous breed Ningxiang pig reveals diverse coding and non-coding RNAs for immunity regulation
    Biao Li, Jinzeng Yang, Jun He, Xing Peng, Qinghua Zeng, Yukun Song, Kang Xu, Haiming Ma · 2021 · Genomics
  23. Juglone eliminates MDSCs accumulation and enhances antitumor immunity
    Hefei Wang, Chendan Zou, Weiyang Zhao, Yuan Yu, Yuqi Cui, He Zhang, Fang E., Zini Qiu, Chaoxia Zou, Xu Gao · 2019 · International Immunopharmacology
  24. Anti-α-enolase antibody limits the invasion of myeloid-derived suppressor cells and attenuates their restraining effector T cell response
    Paola Cappello, Elisabetta Tonoli, Roberta Curto, Daniele Giordano, Mirella Giovarelli, Francesco Novelli · 2015 · OncoImmunology
  25. Current Immunotherapeutic Strategies to Enhance Oncolytic Virotherapy
    Daniel E. Meyers, Amanda A. Wang, Chandini M. Thirukkumaran, Don G. Morris · 2017 · Frontiers in Oncology
  26. Genomic Variations in Pancreatic Cancer and Potential Opportunities for Development of New Approaches for Diagnosis and Treatment
    Shuangshuang Lu, Tasqeen Ahmed, Pan Du, Yaohe Wang · 2017 · International Journal of Molecular Sciences
  27. Identification of LIPH as an unfavorable biomarkers correlated with immune suppression or evasion in pancreatic cancer based on RNA-seq
    Hongkai Zhuang, Xinming Chen, Ying Wang, Shanzhou� Huang, Bo Chen, Chuanzhao Zhang, Baohua Hou · 2021 · Cancer Immunology Immunotherapy
  28. CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality
    Carlo Sorrentino, Luigi D’Antonio, Stefania Livia Ciummo, Cristiano Fieni, Lorena Landuzzi, Francesca Ruzzi, Simone Vespa, Paola Lanuti, Lavinia Vittoria Lotti, Pier‐Luigi Lollini et al. · 2022 · Journal of Hematology & Oncology
  29. Systemic Alterations in Type-2 Conventional Dendritic Cells Lead to Impaired Tumor Immunity in Pancreatic Cancer
    C. Alston James, John M. Baer, Chong Zou, Usman Younis Panni, Brett L. Knolhoff, Graham D. Hogg, Natalie L. Kingston, Liang‐I Kang, Varintra E. Lander, Jingqin Rosy Luo et al. · 2023 · Cancer Immunology Research
  30. In Vitro Study of Genes and Molecular Pathways Differentially Regulated by Synchrotron Microbeam Radiotherapy
    Yuqing Yang, Jeffrey C Crosbie, Premila Paiva, Mohammad Johari Ibahim, Andrew W. Stevenson, Peter A. W. Rogers · 2014 · Radiation Research
  31. Inflammation and Cancer
    Sushil Kumar, Christopher J. Chan, Lisa M. Coussens · 2016 · Elsevier eBooks
  32. Irreversible electroporation promotes a pro-inflammatory tumor microenvironment and anti-tumor immunity in a mouse pancreatic cancer model
    Khan Mohammad Imran, Rebecca Michaela Brock, Natalie Beitel-White, Manali Powar, Katie Orr, Kenneth N. Aycock, Nastaran Alinezhadbalalami, Zaid S. Salameh, Paige Eversole, Benjamin Tintera et al. · 2024 · Frontiers in Immunology
  33. The Role of Tumor Microenvironment in Pancreatic Cancer Immunotherapy: Current Status and Future Perspectives
    Fotini Poyia, Christiana Michael Neophytou, Maria Christodoulou, Panagiotis Papageorgis · 2024 · International Journal of Molecular Sciences
  34. A Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth and Induces Antitumor Immunity in Gastrointestinal Cancer
    Jeremy B. Foote, Tyler Ernest Mattox, Adam B. Keeton, Xi Chen, Forrest Smith, Kristy L. Berry, Thomas W. Holmes, Junwei Wang, Chung-Hui Huang, Antonio Ward et al. · 2024 · Cancer Research
  35. Metastatic heterogeneity in pancreatic cancer: mechanisms and opportunities for targeted intervention
    Ravikanth Maddipati · 2025 · Journal of Clinical Investigation
  36. Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer
    Maria Angela Aznar, Charly Ryan Good, Julie S. Barber-Rotenberg, Sangya Agarwal, Wesley V. Wilson, Alex Watts, Zhen Zhang, Donna M. Gonzales, Greg Donahue, Wei-Ting Hwang et al. · 2025 · Cell Reports Medicine
  37. B3GNT3 overexpression promotes tumor progression and inhibits infiltration of CD8+ T cells in pancreatic cancer
    Hongkai Zhuang, Zixuan Zhou, Zedan Zhang, Xinming Chen, Zuyi Ma, Shanzhou� Huang, Yuanfeng Gong, Chuanzhao Zhang, Baohua Hou · 2020 · Aging
  38. Therapeutic Targeting of the Tumour Microenvironment in Metastatic Colorectal Cancer
    Rhynelle S. Dmello, Sarah Q. To, Ashwini L. Chand · 2021 · International Journal of Molecular Sciences
  39. Impact of cancer cell-intrinsic features on neutrophil behavior
    Danique E. M. Duits, Karin E. de Visser · 2021 · Seminars in Immunology
  40. CCL2-mediated monocytes regulate immune checkpoint blockade resistance in pancreatic cancer
    Xiaocui Li, Guijun He, Jican Liu, Meizhu Yan, Manru Shen, Linfang Xu, Min Ji An, Jiying Huang, Zhenjun Gao · 2022 · International Immunopharmacology
  41. RETRACTED: Coagulation and inflammation in cancer: Limitations and prospects for treatment
    Arun Kumar Singh, Rishabha Malviya · 2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · Retracted
  42. Targeting the metabolism and immune system in pancreatic ductal adenocarcinoma: Insights and future directions
    Dhana Sekhar Reddy Bandi, Sujith Sarvesh, Batoul Farran, Ganji Purnachandra Nagaraju, Bassel F. El‐Rayes · 2023 · Cytokine & Growth Factor Reviews
  43. The Endothelin-Integrin Axis Is Involved in Macrophage-induced Breast Cancer Cell Chemotactic Interactions with Endothelial Cells
    Chia‐Chi Chen, Lili Chen, Yu-Ting Hsu, Ko‐Jiunn Liu, Chi-Shuan Fan, Tze‐Sing Huang · 2014 · Journal of Biological Chemistry
  44. Rab27a regulates GM-CSF-dependent priming of neutrophil exocytosis
    Mahalakshmi Ramadass, Jennifer Linda Johnson, Sergio Daniel Catz · 2016 · Journal of Leukocyte Biology
  45. The protumorigenic potential of FTY720 by promoting extramedullary hematopoiesis and MDSC accumulation
    Yuanyuan Li, Tian Zhou, Y Wang, Changwen Ning, Zongqiang Lv, Gencheng Han, Jonathan C. Morris, Elysha N. Taylor, Renxi Wang, Hai‐Yun Xiao et al. · 2017 · Oncogene
  46. Cancer Manipulation of Host Physiology: Lessons from Pancreatic Cancer
    Constantinos Pantelis Zambirinis, George Miller · 2017 · Trends in Molecular Medicine
  47. Multicolor Flow Cytometric Analysis of Immune Cell Subsets in Tumor-Bearing Mice
    Lauren J. Bayne, Robert H. Vonderheide · 2013 · Cold Spring Harbor Protocols
  48. RETRACTED: HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal adenocarcinoma
    Haotian Wang, Rujiang Jia, Tiansuo Zhao, Xin Li, Mingxiao Lang, Chungen Lan, Hongwei Wang, Zengxun Li, Bodong Zhou, Liangliang Wu et al. · 2019 · Cancer Letters · Retracted
  49. Exosomes in the lung cancer microenvironment: biological functions and potential use as clinical biomarkers
    Runzhi Qi, Yuwei Zhao, Qiujun Guo, Xue Mi, Mengqi Cheng, Wei Hou, Honggang Zheng, Baojin Hua · 2021 · Cancer Cell International
  50. Granulocyte-Macrophage Colony-Stimulating Factor Modulates Myeloid-Derived Suppressor Cells and Treg Activity in Decompensated Cirrhotic Patients With Sepsis
    Rashi Sehgal, Rakhi Maiwall, Rajan Vijayaraghavan, Mojahidul Islam, Sukriti Baweja, Navkiran Kaur, Guresh Kumar, Gayatri Ramakrishna, Shiv Kumar Sarin, Nirupma Trehanpati · 2022 · Frontiers in Immunology
  51. Implantation of GL261 neurospheres into C57/BL6 mice: A more reliable syngeneic graft model for research on glioma-initiating cells
    Yi Liang, CHUN ZHOU, Bing Wang, Tunan Chen, Minhui Xu, Lunshan Xu, Hua Feng · 2013 · International Journal of Oncology
  52. Have lessons from past failures brought us closer to the success of immunotherapy in metastatic pancreatic cancer?
    Laura Rosa Brunet, Thorsten Hagemann, Andrew M. Gaya, Satvinder Mudan, Aurélien Marabelle · 2015 · OncoImmunology
  53. G-CSF promotes alloregulatory function of MDSCs through a c-Kit dependent mechanism
    Young Shin Lee, Vikas Saxena, Jonathan S. Bromberg, Joseph R. Scalea · 2021 · Cellular Immunology
  54. Multimodal Therapies against Pancreatic Ductal Adenocarcinoma: A Review on Synergistic Approaches toward Ultimate Nanomedicine Treatments
    Marzia Conte, Valentina Cauda · 2022 · Advanced Therapeutics
  55. Functional and Clinical Proteomic Exploration of Pancreatic Cancer
    Peiwu Huang, Weina Gao, Changying Fu, Ruijun Tian · 2023 · Molecular & Cellular Proteomics
  56. Intratumoral Heterogeneity in Lung Cancer
    Xiaodi Lv, Zi-Xian Mao, Xian-Jun Sun, Bao-Jun Liu · 2023 · Cancers
  57. Immune Suppression Mediated by Myeloid and Lymphoid Derived Immune Cells in the Tumor Microenvironment Facilitates Progression of Thyroid Cancers Driven by HrasG12V and Pten Loss
    Lee Ann Jolly, Nicole A. Massoll, Aime T. Franco · 2016 · Journal of Clinical & Cellular Immunology
  58. Therapeutic Potential of Targeting Stromal Crosstalk-Mediated Immune Suppression in Pancreatic Cancer
    Wenting Du, Marina Pasca di Magliano, Yaqing Zhang · 2021 · Frontiers in Oncology
  59. The addition of recombinant vaccinia HER2/neu to oncolytic vaccinia-GMCSF given into the tumor microenvironment overcomes MDSC-mediated immune escape and systemic anergy
    Christiaan R. de Vries, Claude E. Monken, Edmund C. Lattime · 2015 · Cancer Gene Therapy
  60. Low-Intensity Focused Ultrasound Produces Immune Response in Pancreatic Cancer
    Jordan B. Joiner, Nancy Porterfield Kren, Phillip G. Durham, Autumn J. McRee, Paul A. Dayton, Yuliya Pylayeva‐Gupta · 2022 · Ultrasound in Medicine & Biology
  61. Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Nanovesicles
    Victor Blanco, Tahir Latif, Zhengtao Chu, Xiaoyang Qi · 2015 · Translational Oncology
  62. Conditioned media from the renal cell carcinoma cell line 786.O drives human blood monocytes to a monocytic myeloid-derived suppressor cell phenotype
    Shannon L. Okada, Randi M. Simmons, Secil Franke-Welch, Thuy Ha Nguyen, Alan J. Korman, Stacey R. Dillon, Debra G. Gilbertson · 2017 · Cellular Immunology
  63. Role of Myeloid-Derived Suppressor Cells in High-Dose-Irradiated TRAMP-C1 Tumors: A Therapeutic Target and an Index for Assessing Tumor Microenvironment
    Sheng‐Yung Fu, George T.Y. Chen, Chun‐Chieh Wang, Ching‐Fang Yu, Chi‐Shiun Chiang, Ji‐Hong Hong · 2020 · International Journal of Radiation Oncology*Biology*Physics
  64. miRNA dynamics in tumor-infiltrating myeloid cells modulating tumor progression in pancreatic cancer
    Leonie Mühlberg, Benjamin Kühnemuth, Eithne Costello, Victoria E. Shaw, Bence Sipos, Magdalena Huber, Heidi Griesmann, Sebastian Krug, Marvin Schober, Thomas Mathias Gress et al. · 2016 · OncoImmunology
  65. Focus on Pancreatic Cancer Microenvironment
    Fabiana Pratticò, Ingrid Garajová · 2024 · Current Oncology
  66. Translational Potential of Therapeutics Targeting Regulatory Myeloid Cells in Tuberculosis
    Nelita du Plessis, Leigh A. Kotzé, Vinzeigh Leukes, Gerhard Walzl · 2018 · Frontiers in Cellular and Infection Microbiology
  67. Promising new treatments for pancreatic cancer in the era of targeted and immune therapies.
    Ahmed Elaileh, Ashish Saharia, Lucy M. Potter, Flavio Egidio Baio, Afnan N. Ghafel, Maen Abdelrahim, Kirk Heyne · 2019 · Europe PMC (PubMed Central)
  68. Immunotherapy and Pancreatic Cancer: A Lost Challenge?
    Carmelo Laface, Riccardo Memeo, Felicia Maria Maselli, Anna Natalizia Santoro, Maria Laura Iaia, Francesca Ambrogio, Marigia Laterza, Gerardo Cazzato, Chiara Guarini, Pierluigi De Santis et al. · 2023 · Life
  69. Case–Control Estimation of the Impact of Oncolytic Adenovirus on the Survival of Patients With Refractory Solid Tumors
    Anna Kanerva, Anniina Koski, Ilkka Liikanen, Minna Oksanen, Timo K. Joensuu, Otto Hemminki, Juni Palmgren, Kari Hemminki, Akseli Hemminki · 2014 · Molecular Therapy
  70. Tumor cross-talk networks promote growth and support immune evasion in pancreatic cancer
    Christopher J. Halbrook, Marina Pasca di Magliano, Costas Andreas Lyssiotis · 2018 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  71. Neoadjuvant BMS-813160, Nivolumab, Gemcitabine, and Nab-Paclitaxel for Patients with Pancreatic Cancer
    Patrick M. Grierson, Crystal Wolf, Rama Suresh, Andrea Wang‐Gillam, Benjamin R. Tan, Lee Ratner, Peter Oppelt, Olivia Aranha, Ashley Elizabeth Frith, Katrina Sophia Pedersen et al. · 2025 · Clinical Cancer Research
  72. Phenotypic heterogeneity and tumor immune microenvironment directed therapeutic strategies in pancreatic ductal adenocarcinoma
    Remya P. G. Ramesh, Hadida Yasmin, Pretty Ponnachan, Basel K. al-Ramadi, Uday Kishore, Ann Mary Joseph · 2025 · Frontiers in Immunology
  73. The immunoregulation effect of tumor microenvironment in pancreatic ductal adenocarcinoma
    Jingchang Zhang, Renfeng Li, Shuai Huang · 2022 · Frontiers in Oncology
  74. FAK promotes stromal PD-L2 expression associated with poor survival in pancreatic cancer
    Catherine Davidson, David Taggart, Andrew H. Sims, David W. Lonergan, Marta Canel, Alan Serrels · 2022 · British Journal of Cancer
  75. G-CSF rescue of FOLFIRINOX-induced neutropenia leads to systemic immune suppression in mice and humans
    Victoire Cardot‐Ruffino, Naïma Böllenrücher, Luisa Delius, S. Jennifer Wang, Lauren K. Brais, Joshua Remland, C. Elizabeth Keheler, Keri M. Sullivan, Thomas Adam Abrams, Leah H. Biller et al. · 2023 · Journal for ImmunoTherapy of Cancer
  76. The mesenchyme in malignancy: A partner in the initiation, progression and dissemination of cancer
    Mark A. Glaire, Emad M. El-Omar, Timothy Cragin Wang, Daniel L. Worthley · 2012 · Pharmacology & Therapeutics
  77. Snail Cooperates with KrasG12D In Vivo to Increase Stem Cell Factor and Enhance Mast Cell Infiltration
    Lawrence M. Knab, Kazumi Ebine, Christina R. Chow, Sania S. Raza, Vaibhav Sahai, Akash P. Patel, Krishan Kumar, David J. Bentrem, Paul J. Grippo, Hidayatullah G. Munshi · 2014 · Molecular Cancer Research
  78. CXCR3 and Cognate Ligands are Associated with Immune Cell Alteration and Aggressiveness of Pancreatic Ductal Adenocarcinoma
    Andrew C. Cannon, Christopher M. Thompson, H. Carlo Maurer, Pranita Atri, Rakesh Bhatia, Sean C. West, Dario Ghersi, Kenneth P. Olive, Sushil Kumar K, Surinder K. Batra · 2020 · Clinical Cancer Research
  79. KRAS-Driven Tumorigenesis and KRAS-Driven Therapy in Pancreatic Adenocarcinoma
    Minh T. Than, Mark H. O’Hara, Ben Z. Stanger, Kim A. Reiss · 2024 · Molecular Cancer Therapeutics
  80. New insights on extramedullary granulopoiesis and neutrophil heterogeneity in the spleen and its importance in disease
    Rongxia Guo, Xuemei Xie, Qian Ren, Pei Xiong Liew · 2024 · Journal of Leukocyte Biology
  81. Engineering of biomaterials for tumor modeling
    Sae Rome Choi, Yi Yang, Kai‐Yu Huang, Hyunjoon Kong, Matthew J. Flick, Bumsoo Han · 2020 · Materials Today Advances
  82. Granulocytes and Cells of Granulocyte Origin—The Relevant Players in Colorectal Cancer
    Izabela Siemińska, Ewa Poljańska, Jarosław Baran · 2021 · International Journal of Molecular Sciences
  83. Distinct myeloid antigen-presenting cells dictate differential fates of tumor-specific CD8+ T cells in pancreatic cancer
    Adam L. Burrack, Zoe C. Schmiechen, Michael T. Patterson, Ebony A. Miller, Ellen J. Spartz, Meagan R. Rollins, Jackson F. Raynor, Jason S. Mitchell, Tsuneyasu Kaisho, Brian T. Fife et al. · 2022 · JCI Insight
  84. Reprogramming of pancreatic adenocarcinoma immunosurveillance by a microbial probiotic siderophore
    Mehdi Chaib, Bilal Bin Hafeez, Hassan Mandil, Deidre Daria, Ajeeth Kumar Pingili, Sonam Kumari, Mohammed Sikander, Vivek Kumar Kashyap, Guo‐Yun Chen, Emmanuel Anning et al. · 2022 · Communications Biology
  85. CIS controls the functional polarization of GM-CSF-derived macrophages
    Shengbo Zhang, Jai Rautela, Naiara G. Bediaga, Tatiana B. Kolesnik, Yue You, Junli Nie, Laura F. Dagley, Justin Bedő, Hanqing Wang, Li Jun Sun et al. · 2022 · Cellular and Molecular Immunology
  86. Collectin-11 promotes cancer cell proliferation and tumor growth
    Jiaxing Wang, Bo Cao, Ning Ma, Kunyi Wu, Wan-Bing Chen, Weiju Wu, Xia Dong, Chengfei Liu, Ya-Feng Gao, Teng‐Yue Diao et al. · 2023 · JCI Insight
  87. Cancer as a Disease of Development Gone Awry
    Ben Z. Stanger, Geoffrey M. Wahl · 2023 · Annual Review of Pathology Mechanisms of Disease
  88. Identification of hub genes and potential molecular mechanisms related to drug sensitivity in acute myeloid leukemia based on machine learning
    Boyu Zhang, Haiyan Liu, Fengxia Wu, Yuhong Ding, Jiarun Wu, Lu Lu, Akhilesh Kumar Bajpai, Mengmeng Sang, Xinfeng Wang · 2024 · Frontiers in Pharmacology
  89. Myeloid derived suppressor cells in cancer, premalignancy and inflammation: A roadmap to cancer immunoprevention
    Umayal Sivagnanalingam, Pamela L. Beatty, Olivera J. Finn · 2020 · Molecular Carcinogenesis
  90. Role of different immune cells and metabolic pathways in modulating the immune response in pancreatic cancer (Review)
    Nnenna Elebo, Pascaline Fru, J. Omoshoro–Jones, Geoffrey Patrick Candy, Ekene Emmanuel Nweke · 2020 · Molecular Medicine Reports
  91. Modulation of Early Neutrophil Granulation: The Circulating Tumor Cell-Extravesicular Connection in Pancreatic Ductal Adenocarcinoma
    Harrys Charles Jacob, John Lalith Charles Richard, Rossana Signorelli, Tyler Kashuv, Shweta Lavania, Utpreksha Vaish, Ranjitha Boopathy, Ashley Nicole Middleton, Melinda Boone, Ramakrishnan Sundaram et al. · 2021 · Cancers
  92. Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX
    Hye Eun Park, Seung-Yeon Yoo, Nam‐Yun Cho, Jeong Mo Bae, Sae‐Won Han, Hye Seung Lee, Kyu Joo Park, Tae‐You Kim, Gyeong Hoon Kang · 2021 · Scientific Reports
  93. CAR-T Cells for the Treatment of Lung Cancer
    Luisa Chocarro, Hugo Arasanz, Leticia Fernández, Ester Blanco, Miriam Echaide, Ana Bocanegra, Lucía Teijeira, Maider Garnica, Idoia Morilla, Maite Martínez-Aguillo et al. · 2022 · Life
  94. Inflammatory Cytokine Signaling during Development of Pancreatic and Prostate Cancers
    Geou‐Yarh Liou · 2017 · Journal of Immunology Research
  95. Mechanism of enhancing chemotherapy efficacy in pancreatic ductal adenocarcinoma with paricalcitol and hydroxychloroquine
    Ganji Purnachandra Nagaraju, Madhu Sudhana Saddala, Jeremy B. Foote, Ateeq Muhammed Khaliq, Ashiq Masood, Yuvasri Golivi, Dhana Sekhar Reddy Bandi, Sujith Sarvesh, Sudhir Putty Reddy, Jeffrey M. Switchenko et al. · 2024 · Cell Reports Medicine
  96. Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies
    Taymin du Toit‐Thompson, Lionel Yi Wen Leck, Josef Gillson, Nick Pavlakis, Anthony James Gill, Jaswinder Singh Samra, Anubhav Mittal, Sumit Sahni · 2025 · Advanced Drug Delivery Reviews
  97. Challenges and Perspectives for Immunotherapy in Adenocarcinoma of the Pancreas
    Markus Kieler, Matthias Unseld, Daniela Bianconi, Gerald W. Prager · 2018 · Pancreas
  98. Pancreatic cancer-associated inflammation drives dynamic regulation of p35 and Ebi3
    Daniel E. Michaud, Bhalchandra Mirlekar, Steve R. Bischoff, Dale O. Cowley, Dario A.A. Vignali, Yuliya Pylayeva‐Gupta · 2019 · Cytokine
  99. The biology of pancreatic cancer morphology
    Oliver Gene McDonald · 2021 · Pathology
  100. Tumour microenvironment and heterotypic interactions in pancreatic cancer
    Raúl Muñoz Velasco, Ana García García, Paula Jiménez Sánchez, Inmaculada Montanuy Sellart, Victor Javier Sanchez-Arevalo Lobo · 2022 · Journal of Physiology and Biochemistry